Scott Mendel Insider Trading $GNMK GenMark Diagnostics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott Mendel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott Mendel. Scott Mendel is Chief Financial Officer in ACTIVE NETWORK INC ($ACTV) and Chief Financial Officer in GenMark Diagnostics, Inc. ($GNMK) and Chief Operating Officer in GenMark Diagnostics, Inc. ($GNMK) and Interim President & CEO in GenMark Diagnostics, Inc. ($GNMK) and President & CEO in GenMark Diagnostics, Inc. ($GNMK).
Scott Mendel in GenMark Diagnostics, Inc.
Trading Symbol: GNMKIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Scott Mendel: Interim President & CEO, Chief Operating Officer, Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 22 2021
$GNMK Market Capitalization: $508.12M
$GNMK Previous Close: $11.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Scott Mendel in GenMark Diagnostics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Option Exercise | D | 13.17 | 35,552 | 468,220 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Option Exercise | D | 9.43 | 84,002 | 792,139 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Option Exercise | D | 0.00 | 53,382 | 0 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Option Exercise | D | 0.00 | 100,000 | 0 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Option Exercise | D | 0.00 | 28,332 | 0 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Sell | U | 24.05 | 115,491 | 2,777,559 | 0 | 115.5 K to 0 (-100.00 %) |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Sell | U | 24.05 | 507,198 | 12,198,112 | 0 | 507.2 K to 0 (-100.00 %) |
Mar 01 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Payment of Exercise | F | 0.00 | 41,834 | 0 | 507,198 | 549 K to 507.2 K (-7.62 %) |
Feb 25 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Payment of Exercise | F | 0.00 | 3,254 | 0 | 549,032 | 552.3 K to 549 K (-0.59 %) |
Feb 24 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Payment of Exercise | F | 0.00 | 1,860 | 0 | 552,286 | 554.1 K to 552.3 K (-0.34 %) |
Feb 22 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Option Exercise | A | 0.00 | 26,691 | 0 | 26,691 | |
Feb 22 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Grant | A | 0.00 | 80,070 | 0 | 554,146 | 474.1 K to 554.1 K (+16.89 %) |
Feb 22 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Payment of Exercise | F | 0.00 | 3,952 | 0 | 474,076 | 478 K to 474.1 K (-0.83 %) |
Jan 25 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Sell | S | 14.23 | 64,975 | 924,594 | 478,028 | 543 K to 478 K (-11.97 %) |
Jan 21 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Option Exercise | M | 0.00 | 50,000 | 0 | 50,000 | |
Jan 21 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Option Exercise | M | 0.00 | 46,098 | 0 | 14,167 | |
Jan 21 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Option Exercise | M | 0.00 | 50,074 | 0 | 0 | |
Jan 21 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Buy | M | 0.00 | 50,000 | 0 | 543,002 | 493 K to 543 K (+10.14 %) |
Jan 21 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Buy | M | 0.00 | 46,098 | 0 | 493,002 | 446.9 K to 493 K (+10.31 %) |
Jan 21 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Buy | M | 0.00 | 50,074 | 0 | 446,904 | 396.8 K to 446.9 K (+12.62 %) |
Jan 21 2021 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Sell | S | 14.54 | 50,000 | 727,000 | 115,491 | 165.5 K to 115.5 K (-30.21 %) |
Nov 25 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Sell | S | 13.17 | 5,190 | 68,352 | 396,830 | 402 K to 396.8 K (-1.29 %) |
Nov 20 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Sell | S | 13.85 | 3,987 | 55,220 | 402,020 | 406 K to 402 K (-0.98 %) |
Aug 28 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Sell | S | 15.02 | 50,000 | 751,000 | 81,690 | 131.7 K to 81.7 K (-37.97 %) |
Aug 26 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Sell | S | 14.14 | 4,532 | 64,082 | 489,808 | 494.3 K to 489.8 K (-0.92 %) |
Aug 24 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Sell | S | 15.41 | 2,988 | 46,045 | 494,340 | 497.3 K to 494.3 K (-0.60 %) |
Aug 14 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Sell | S | 15.08 | 50,000 | 754,000 | 131,690 | 181.7 K to 131.7 K (-27.52 %) |
Jun 02 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Grant | A | 0.00 | 50,000 | 0 | 497,328 | 447.3 K to 497.3 K (+11.18 %) |
Jun 01 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Sell | S | 9.52 | 3,751 | 35,710 | 447,328 | 451.1 K to 447.3 K (-0.83 %) |
May 20 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | President & CEO | Sell | S | 10.46 | 2,800 | 29,288 | 451,079 | 453.9 K to 451.1 K (-0.62 %) |
Feb 28 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | Interim President & ... | Sell | S | 3.51 | 2,659 | 9,333 | 547,111 | 549.8 K to 547.1 K (-0.48 %) |
Feb 27 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | Interim President & ... | Option Exercise | A | 0.00 | 75,000 | 0 | 75,000 | |
Feb 27 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | Interim President & ... | Sell | S | 3.81 | 1,402 | 5,342 | 549,770 | 551.2 K to 549.8 K (-0.25 %) |
Feb 27 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | Interim President & ... | Grant | A | 0.00 | 112,500 | 0 | 551,172 | 438.7 K to 551.2 K (+25.65 %) |
Feb 27 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | Interim President & ... | Grant | A | 0.00 | 112,500 | 0 | 438,672 | 326.2 K to 438.7 K (+34.49 %) |
Feb 21 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | Interim President & ... | Sell | S | 3.80 | 14,536 | 55,237 | 326,172 | 340.7 K to 326.2 K (-4.27 %) |
Jan 23 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Option Exercise | M | 0.00 | 10,568 | 0 | 31,932 | |
Jan 23 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Option Exercise | M | 0.00 | 7,129 | 0 | 15,074 | |
Jan 23 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 4.92 | 7,652 | 37,648 | 340,708 | 348.4 K to 340.7 K (-2.20 %) |
Jan 23 2020 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Buy | M | 0.00 | 17,697 | 0 | 348,360 | 330.7 K to 348.4 K (+5.35 %) |
Nov 26 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 5.43 | 5,206 | 28,269 | 330,663 | 335.9 K to 330.7 K (-1.55 %) |
Nov 21 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 5.55 | 2,701 | 14,991 | 335,869 | 338.6 K to 335.9 K (-0.80 %) |
Nov 21 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 5.55 | 2,701 | 14,991 | 335,869 | 338.6 K to 335.9 K (-0.80 %) |
Aug 30 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 6.03 | 3,685 | 22,221 | 338,570 | 342.3 K to 338.6 K (-1.08 %) |
Aug 21 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 6.25 | 1,967 | 12,294 | 342,255 | 344.2 K to 342.3 K (-0.57 %) |
May 31 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 6.60 | 2,304 | 15,206 | 344,222 | 346.5 K to 344.2 K (-0.66 %) |
May 28 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 6.62 | 1,371 | 9,076 | 346,526 | 347.9 K to 346.5 K (-0.39 %) |
May 22 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 6.83 | 1,907 | 13,025 | 347,897 | 349.8 K to 347.9 K (-0.55 %) |
Feb 27 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 6.80 | 11,410 | 77,588 | 349,804 | 361.2 K to 349.8 K (-3.16 %) |
Feb 21 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Option Exercise | A | 0.00 | 42,500 | 0 | 42,500 | |
Feb 21 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Sell | S | 6.16 | 2,063 | 12,708 | 361,214 | 363.3 K to 361.2 K (-0.57 %) |
Feb 21 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Operating Off ... | Grant | A | 0.00 | 127,500 | 0 | 363,277 | 235.8 K to 363.3 K (+54.08 %) |
Jan 25 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 5.90 | 5,297 | 31,252 | 235,777 | 241.1 K to 235.8 K (-2.20 %) |
Jan 22 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Option Exercise | M | 0.00 | 12,800 | 0 | 22,200 | |
Jan 22 2019 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Buy | M | 0.00 | 12,800 | 0 | 241,074 | 228.3 K to 241.1 K (+5.61 %) |
Nov 29 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 5.08 | 1,292 | 6,563 | 228,274 | 229.6 K to 228.3 K (-0.56 %) |
Nov 26 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 4.84 | 1,959 | 9,482 | 229,566 | 231.5 K to 229.6 K (-0.85 %) |
Nov 26 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 4.84 | 1,959 | 9,482 | 229,566 | 231.5 K to 229.6 K (-0.85 %) |
Nov 06 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 4.85 | 226 | 1,096 | 231,525 | 231.8 K to 231.5 K (-0.10 %) |
Aug 27 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 7.16 | 1,361 | 9,745 | 231,751 | 233.1 K to 231.8 K (-0.58 %) |
Aug 22 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 7.39 | 1,915 | 14,152 | 233,112 | 235 K to 233.1 K (-0.81 %) |
Aug 07 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 7.20 | 207 | 1,490 | 235,027 | 235.2 K to 235 K (-0.09 %) |
May 24 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 6.88 | 1,312 | 9,027 | 235,234 | 236.5 K to 235.2 K (-0.55 %) |
May 22 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 6.91 | 1,904 | 13,157 | 236,546 | 238.5 K to 236.5 K (-0.80 %) |
May 17 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 6.60 | 1,218 | 8,039 | 238,450 | 239.7 K to 238.5 K (-0.51 %) |
May 04 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 6.18 | 218 | 1,347 | 239,668 | 239.9 K to 239.7 K (-0.09 %) |
Feb 27 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
Feb 27 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 4.17 | 6,275 | 26,167 | 239,886 | 246.2 K to 239.9 K (-2.55 %) |
Feb 27 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Grant | A | 0.00 | 117,000 | 0 | 246,161 | 129.2 K to 246.2 K (+90.58 %) |
Feb 21 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 4.37 | 2,304 | 10,068 | 129,161 | 131.5 K to 129.2 K (-1.75 %) |
Feb 15 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 4.54 | 1,391 | 6,315 | 131,465 | 132.9 K to 131.5 K (-1.05 %) |
Feb 06 2018 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 5.13 | 258 | 1,324 | 132,856 | 133.1 K to 132.9 K (-0.19 %) |
Nov 21 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 4.74 | 2,879 | 13,646 | 133,114 | 136 K to 133.1 K (-2.12 %) |
Nov 15 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 4.71 | 1,777 | 8,370 | 135,993 | 137.8 K to 136 K (-1.29 %) |
Nov 03 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 7.24 | 326 | 2,360 | 137,770 | 138.1 K to 137.8 K (-0.24 %) |
Aug 23 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 9.45 | 2,898 | 27,386 | 138,096 | 141 K to 138.1 K (-2.06 %) |
Aug 15 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 10.16 | 1,752 | 17,800 | 140,994 | 142.7 K to 141 K (-1.23 %) |
Aug 04 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 10.33 | 333 | 3,440 | 142,746 | 143.1 K to 142.7 K (-0.23 %) |
May 23 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 12.89 | 2,135 | 27,520 | 143,079 | 145.2 K to 143.1 K (-1.47 %) |
May 17 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 13.43 | 1,268 | 17,029 | 145,214 | 146.5 K to 145.2 K (-0.87 %) |
May 04 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 13.34 | 232 | 3,095 | 162,529 | 162.8 K to 162.5 K (-0.14 %) |
Feb 24 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Feb 24 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Grant | A | 0.00 | 60,000 | 0 | 162,761 | 102.8 K to 162.8 K (+58.39 %) |
Feb 21 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 10.08 | 8,595 | 86,638 | 102,761 | 111.4 K to 102.8 K (-7.72 %) |
Feb 16 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 10.98 | 1,274 | 13,989 | 111,356 | 112.6 K to 111.4 K (-1.13 %) |
Feb 03 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 11.58 | 235 | 2,721 | 112,630 | 112.9 K to 112.6 K (-0.21 %) |
Jan 20 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Option Exercise | M | 0.00 | 9,698 | 0 | 19,396 | |
Jan 20 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,689 | 0 | 5,798 | |
Jan 20 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 12.47 | 9,098 | 113,452 | 133,301 | 142.4 K to 133.3 K (-6.39 %) |
Jan 20 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Buy | M | 0.00 | 18,875 | 0 | 160,933 | 142.1 K to 160.9 K (+13.29 %) |
Jan 20 2017 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Buy | M | 0.00 | 3,689 | 0 | 142,058 | 138.4 K to 142.1 K (+2.67 %) |
Nov 17 2016 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Sell | S | 12.77 | 1,271 | 16,231 | 138,369 | 139.6 K to 138.4 K (-0.91 %) |
Feb 22 2016 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Option Exercise | A | 0.00 | 29,094 | 0 | 29,094 | |
Feb 22 2016 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Grant | A | 0.00 | 87,197 | 0 | 139,640 | 52.4 K to 139.6 K (+166.27 %) |
Jan 25 2016 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Option Exercise | M | 0.00 | 298 | 0 | 9,487 | |
Jan 25 2016 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Buy | M | 0.00 | 298 | 0 | 52,443 | 52.1 K to 52.4 K (+0.57 %) |
Nov 02 2015 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Buy | P | 6.47 | 10,000 | 64,700 | 33,441 | 23.4 K to 33.4 K (+42.66 %) |
Aug 25 2015 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Buy | P | 9.10 | 10,000 | 91,000 | 23,441 | 13.4 K to 23.4 K (+74.40 %) |
Feb 23 2015 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Option Exercise | A | 0.00 | 9,785 | 0 | 9,785 | |
Feb 23 2015 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Option Exercise | A | 13.17 | 35,552 | 468,220 | 35,552 | |
Feb 23 2015 | GNMK | GenMark Diagnostic ... | Mendel Scott | Chief Financial Off ... | Grant | A | 0.00 | 11,822 | 0 | 65,586 | 53.8 K to 65.6 K (+21.99 %) |
Page: 1